Content and data provided by various third parties and Fidelity − Terms of Use | Help/Glossary
Research > ETFs > ETF / ETP Commentary > 

Trump in Beijing: Keep an Eye on These 3 China ETFs

BY | ETF Database
05/13/2026 | 11 VIEWS
If advisors and investors haven’t been keeping a close eye on the Chinese market recently, now may be a very good time to start doing so. On Wednesday, President Trump headed off to Beijing for a two-day summit, marking the first time a U.S. president has visited China in nearly a decade. Among other topics, the two economic behemoths are expected to discuss a wide variety of trade-related issues. Naturally, this Xi summit could play out very well in favor of Xi’s  China-focused strategies. KWEB: Target China's Ever-Growing Tech IndustryThere are plenty of different ways to get access to Chinese companies via the flexible ETF wrapper. For instance, the KraneShares CSI China Internet ETF (KWEB B) is a good place to start. KWEB leverages KraneShares’ expertise in navigating the Chinese markets to provide focused exposure to companies tied to internet or internet-related tech. This approach allows the fund to ride out plenty of favorable techy tailwinds in China, like AI innovation.  Already, evidence is mounting that KWEB could see renewed interest amid better diplomatic relations between the U.S. and China. Between April 11, 2026, and May 11, 2026, the fund has seen over $500 million in net flows.  See more: China Underrated? Get China Equities in Emerging Markets ETF GEMMCHI: Holistic Exposure to the Chinese MarketFor those looking for more of a broad take on Chinese equity exposure, the iShares MSCI China ETF (MCHI A) could help. This BlackRock fund focuses on investing in both large- and mid-cap companies in China, offering a balanced view of the Chinese market.  Even before President Trump stepped foot in China this year, MCHI was offering annual returns in the green. The fund’s NAV has risen 4.85% over the last year, as of March 31, 2026. This number could go much higher if China’s trade relationship with the U.S. enters a more positive space.CXSE: The Advantages of Minimizing Government InterferenceAnother China-focused fund that may offer an interesting use case is the WisdomTree China ex-State-Owned Enterprises Fund (CXSE A-). CXSE invests in Chinese companies that are not ‘state-owned enterprises’, which are companies with government ownership greater than 20%. As one could imagine, investors may gain a competitive edge through exposure to private sector firms with more independence to focus on market incentives.    See more: Sprott Launches REXC: The First Ex-China Rare Earths ETF Notably, CXSE has seen impressive recent returns, highlighting the advantages of its approach. As of April 30, 2026, the fund’s NAV had risen 7.63% from the previous month.  Ultimately, these three funds demonstrate how the adaptable ETF framework allows advisors and investors to capture diverse themes within the Chinese market. Of course with President Trump in China attending the summit for the next days, now may be an ideal time to hop on these equities as trade conditions may be entering a sunnier spot.  For more news, information, and strategy, visit ETFdb.

More Commentary

Navigating the Small-Cap ETF Disconnect
BY | ETF Database
05/13/2026 | 27 VIEWS
ETF Prime: Space & AI Infrastructure in Focus
BY | ETF Database
05/13/2026 | 39 VIEWS
Why the Healthcare Sector Warrants Concentrated Exposure
BY | ETF Database
05/13/2026 | 20 VIEWS
View more Commentary

Search Commentary

Enter Keyword(s)
Filter Results

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.